vimarsana.com

Latest Breaking News On - Russell micro cap index - Page 3 : vimarsana.com

Is PLx Pharma (PLXP) A Worthy Investment?

Summers Value Partners, an investment management firm, published its “Summers Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Should You Now Consider Selling Your Modivcare (MODV) Shares?

Summers Value Partners, an investment management firm, published its “Summers Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Summers Value Partners: We Have a $90 Price Target on UFPT

Summers Value Partners, an investment management firm, published its “Summers Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Summers Value Partners: Our Price Target on UTMD is $120 per Share

Summers Value Partners, an investment management firm, published its “Summers Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

Summers Value Partners Q4 2021 Investor Letter

Summers Value Partners, an investment management firm, published its “Summers Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.